Opportunity ID: 255972

General Information

Document Type: Grants Notice
Funding Opportunity Number: W81XWH-14-DMDRP-TIA
Funding Opportunity Title: DoD Duchenne Muscular Dystrophy Therapeutic Idea Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 3
Posted Date: May 27, 2014
Last Updated Date: May 27, 2014
Original Closing Date for Applications: Oct 22, 2014
Current Closing Date for Applications: Oct 22, 2014
Archive Date: Nov 21, 2014
Estimated Total Program Funding: $480,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description: The DMDRP Therapeutic Idea Award mechanism was first offered in FY12 and is being offered again in FY14. It is designed to promote new ideas that are still in the early stages of development with the potential to yield high-impact data and new avenues of investigation for novel therapeutics for DMD treatment. This award mechanism supports conceptually innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancement in DMD therapeutics. Research projects should include a well-formulated, testable hypothesis based on strong scientific rationale.Presentation of preliminary data is not consistent with the intent of the Therapeutic Idea Award mechanism. While the inclusion of preliminary data is not prohibited, the strength of the application should not rely on preliminary data.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Phone: (301) 682-5507

Email: help@eBRAP.org
Email:help@eBRAP.org

Version History

Version Modification Description Updated Date
Correcting Estimated Total Program Funding May 27, 2014
Corrected Estimated Total Program Funding May 27, 2014
May 27, 2014

DISPLAYING: Synopsis 3

General Information

Document Type: Grants Notice
Funding Opportunity Number: W81XWH-14-DMDRP-TIA
Funding Opportunity Title: DoD Duchenne Muscular Dystrophy Therapeutic Idea Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 3
Posted Date: May 27, 2014
Last Updated Date: May 27, 2014
Original Closing Date for Applications: Oct 22, 2014
Current Closing Date for Applications: Oct 22, 2014
Archive Date: Nov 21, 2014
Estimated Total Program Funding: $480,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description: The DMDRP Therapeutic Idea Award mechanism was first offered in FY12 and is being offered again in FY14. It is designed to promote new ideas that are still in the early stages of development with the potential to yield high-impact data and new avenues of investigation for novel therapeutics for DMD treatment. This award mechanism supports conceptually innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancement in DMD therapeutics. Research projects should include a well-formulated, testable hypothesis based on strong scientific rationale.Presentation of preliminary data is not consistent with the intent of the Therapeutic Idea Award mechanism. While the inclusion of preliminary data is not prohibited, the strength of the application should not rely on preliminary data.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Phone: (301) 682-5507

Email: help@eBRAP.org
Email:help@eBRAP.org

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: W81XWH-14-DMDRP-TIA
Funding Opportunity Title: DoD Duchenne Muscular Dystrophy Therapeutic Idea Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: May 27, 2014
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: Oct 22, 2014
Archive Date: Nov 21, 2014
Estimated Total Program Funding: $48,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description: The DMDRP Therapeutic Idea Award mechanism was first offered in FY12 and is being offered again in FY14. It is designed to promote new ideas that are still in the early stages of development with the potential to yield high-impact data and new avenues of investigation for novel therapeutics for DMD treatment. This award mechanism supports conceptually innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancement in DMD therapeutics. Research projects should include a well-formulated, testable hypothesis based on strong scientific rationale.Presentation of preliminary data is not consistent with the intent of the Therapeutic Idea Award mechanism. While the inclusion of preliminary data is not prohibited, the strength of the application should not rely on preliminary data.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Phone: (301) 682-5507

Email: help@eBRAP.org
Email:help@eBRAP.org

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: W81XWH-14-DMDRP-TIA
Funding Opportunity Title: DoD Duchenne Muscular Dystrophy Therapeutic Idea Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: May 27, 2014
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: Oct 22, 2014
Archive Date: Nov 21, 2014
Estimated Total Program Funding: $48,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description: The DMDRP Therapeutic Idea Award mechanism was first offered in FY12 and is being offered again in FY14. It is designed to promote new ideas that are still in the early stages of development with the potential to yield high-impact data and new avenues of investigation for novel therapeutics for DMD treatment. This award mechanism supports conceptually innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancement in DMD therapeutics. Research projects should include a well-formulated, testable hypothesis based on strong scientific rationale.

Presentation of preliminary data is not consistent with the intent of the Therapeutic Idea Award mechanism. While the inclusion of preliminary data is not prohibited, the strength of the application should not rely on preliminary data.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Phone: (301) 682-5507

Email: help@eBRAP.org
Email:help@eBRAP.org

Folder 255972 Full Announcement-1 -> DMDRP_FY14 TIA_PA_GG.pdf

Packages

Agency Contact Information: Phone: (301) 682-5507
Email: help@eBRAP.org
Email: help@eBRAP.org
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
12.420 PKG00197364 May 27, 2014 Oct 22, 2014 View

Package 1

Mandatory forms

255972 RR_SF424_2_0-2.0.pdf

255972 RR_Budget_1_3-1.3.pdf

255972 RR_KeyPersonExpanded_2_0-2.0.pdf

255972 PerformanceSite_2_0-2.0.pdf

Optional forms

255972 RR_SubawardBudget30_1_3-1.3.pdf

2025-07-09T12:48:42-05:00

Share This Post, Choose Your Platform!

About the Author: